LARP1 anticorps (AA 275-325)

N° du produit ABIN1909281

Cet anticorps anti-LARP1 est un anticorps Polyclonal produit chez le Lapin, détectant LARP1 dans WB, IF, IHC, IP et IHC (p). Convient pour Humain et Singe.

Aperçu rapide pour LARP1 anticorps (AA 275-325) (ABIN1909281)

Antigène: LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))

Reactivité: Humain, Singe

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LARP1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-LARP1 anticorps

Épitope: AA 275-325

Specificité: Region between residue 275 and 325 of human La ribonucleoprotein domain family, member 1 using the numbering given in entry NP_291029.2 (GeneID 23367).

Purification: Immunoaffinity purified

Isotype: IgG

Information d'application

Indications d'application: Approved: IF (1:50 - 1:250), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)

Usage: Immunohistochemistry: Antigen retrieval with citrate buffer  pH 6.0 is recommended for FFPE tissue sections. Human controls: Colon Carcinoma, Ovarian Carcinoma.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C for up to 1 year.

Date de péremption: 12 months

Détails sur LARP1

Antigène: LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))

Autre désignation: LARP1 / La-Related Protein 1

Sujet: Name/Gene ID: LARP1

Synonyms: LARP1, La-related protein 1, LARP, KIAA0731

ID gène: 23367

Pathways: SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2